Temazepam
(N=9)

Placebo
(n=9)

Gender (N)                 
Male              
Female

 

 

8 (89%)

8 (89%)

1 (11%)

1 (11%)

Ethnicity (N)           
Caucasian        
Hispanic
African American
Unknown                

 

 

4 (44%)

4 (44%)

4 (44%)

4 (44%)

1 (6%)

0 (0%)

0 (0%)

1 (6%)

Age (yrs)

36.22±7.60

33.33±7.92

Education (yrs)

12.44±0.73

11.67±1.50

 Verbal IQ

110.05±7.29

110.75±3.33

METH Drug Use

 

 

Years of use

12.67±8.57

12.22±6.57

^ Recent use

20.00±9.30

16.67±8.63

Grams/week

9.54±9.08

9.54±9.08

Days Abstinent

5.67±1.12

6.67±1.23

Nicotine Use

8 (89%)

7 (78%)

Sleep Quality

 

 

PSQI

8.44±4.67

4.44±2.83*

ESS

9.11±6.57

8.78±2.49

1 Same subject population as reported in Mahoney, 2011
^ Recent use indicates number of days of use of primary drug in the 30 days preceding interview.
*p < 0.05Age, Education, Years of use, and Recent use, Grams/week, Amount Spent/week, Days Abstinent, PSQI, ESS reflect mean ± S. D.
Table 1: Demographic Characteristics1
Goto home»